Patents Examined by Jeffrey T Palenik
-
Patent number: 11986542Abstract: Described herein is a hair care composition including from about 0.01% to about 20% of a lipid being one or more unsaturated fatty materials chosen from unsaturated fatty acids, unsaturated fatty alcohols, and mixtures thereof. The unsaturated fatty material has a Log P of less than 8. The hair care composition also includes from about 0.01% to about 10% of a fatty acid monoester of a polyol, a saturated fatty alcohol, an ester of a saturated fatty alcohol, and mixtures thereof. The molecule of the fatty acid component of the fatty acid monoester includes a linear or a branched carbon chain with 10 to 22 carbon atoms. The fatty acid monoester of a polyol has a log P of less than 8. The molecule of the fatty alcohol includes a linear or branched carbon chain with 8 to 22 carbon atoms. The hair care composition also includes a non-aqueous volatile solvent.Type: GrantFiled: August 24, 2021Date of Patent: May 21, 2024Assignee: The Procter & Gamble CompanyInventors: Jose Antonio Carballada, Lauren Elizabeth Ballhaus, Ron Walker, Jennifer Mary Marsh, Supriya Punyani, Qing Stella, Curtis Bobby Motley, Bernd Findeis, Ingo Peter Herkert
-
Patent number: 11964060Abstract: The invention relates to transparent therapeutic systems (TTS) which contain the active substance nicotine and which further contain at least one acid amide group as a lateral functional group. The TTS can be transparent and for discreet use. The invention also relates to methods for producing these TTS, said TTS being produced by methods using said polymers and being charged with active substance by way of a printing method.Type: GrantFiled: February 26, 2018Date of Patent: April 23, 2024Assignee: LTS Lohmann Therapie-Systeme AGInventors: Thomas Hille, Gabriel Wauer, Petra Botzem, Frank Seibertz
-
Patent number: 11963951Abstract: The present invention relates to the field of methods for providing pharmaceutical compositions comprising poorly water-soluble drugs. In particular the present invention relates to compositions comprising stable, amorphous hybrid nanoparticles, comprising at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component, useful in pharmaceutical compositions and in therapy.Type: GrantFiled: December 16, 2021Date of Patent: April 23, 2024Assignee: XSPRAY PHARMA ABInventors: Magnus Brisander, Mustafa Demirbüker, Gérald Jesson, Martin Malmsten, Helene Dérand
-
Patent number: 11964072Abstract: The present invention relates to a soft tissue adhesive comprising an aqueous composition comprising ?-TCP and a phosphorylated amino acid. The composition has improved mechanical strength and is easily applied to the tissue.Type: GrantFiled: September 27, 2017Date of Patent: April 23, 2024Assignee: BIOMIMETIC INNOVATIONS LIMITEDInventors: Philip Procter, Håkan Engqvist, Michael Pujari-Palmer, Gerard Insley
-
Patent number: 11930831Abstract: The current invention relates to animal food kibbles having a primarily disc shape and including botanicals such as curcumin. The current invention also relates to methods to reduce oral inflammation in an animal by feeding the animal with the food kibbles. The disc-shaped food kibbles induce a reduction of oral inflammation in the animal compared to control food kibbles having a different shape.Type: GrantFiled: December 2, 2019Date of Patent: March 19, 2024Assignee: Hill's Pet Nutrition, Inc.Inventors: Jodi Vondran, Dennis Jewell, Kiran Panickar, Dale Scherl
-
Patent number: 11925630Abstract: A 6?-(2-bromophenyl)-2?-methoxy-3,4?-bipyridine-3?-carbonitrile as antioxidant compound, its synthesis, and its use as an antioxidant agent.Type: GrantFiled: November 1, 2023Date of Patent: March 12, 2024Assignee: KING FAISAL UNIVERSITYInventors: Hany Mohamed Abd El-Lateef Ahmed, Mai Mostafa Khalaf Ali, Antar Ahmed Abdelhamid Ahmed, Amer A. Amer
-
Patent number: 11911490Abstract: The present invention relates to an aerosol device comprising: —a container containing a cosmetic composition which comprises one or more powders in a content of less than 7% by weight relative to the total weight of the composition, and—a dispensing head comprising a body and an end part comprising at least two outlet orifices configured to allow spraying of the composition about a longitudinal axis of the end part in at least two different directions, the dispensing head comprising at least first and second chambers, through which the composition stream successively passes before it exits via the outlet orifices.Type: GrantFiled: August 9, 2021Date of Patent: February 27, 2024Assignee: L'OREALInventors: Lionel Aubert, Céférino Rodrigues, Catherine Tetu
-
Patent number: 11890299Abstract: A method of ablating a target body tissue, such as uterine endometrial lining tissue, includes applying an agent comprising HAuCl4 to the target body tissue, wherein the HAuCl4 has a molecular size greater than 50 microns, and removing the agent comprising HAuCl4 from the target tissue after ablation of the target tissue begins.Type: GrantFiled: May 29, 2020Date of Patent: February 6, 2024Assignee: Hologic, Inc.Inventors: Victor Manuel Solano Umaña, Estefania Alvarez
-
Patent number: 11833253Abstract: An extended release pharmaceutical composition of Clozapine The extended release composition of Clozapine provides an extended release pharmaceutical composition having Clozapine, a seal coating, an acidic coating, and an extended release coating. The composition is particularly suitable for dispensing a once-a-day solid oral pharmaceutical formulation which releases a therapeutically effective amount of Clozapine over an extended time period.Type: GrantFiled: October 17, 2022Date of Patent: December 5, 2023Assignee: INTAS PHARMACEUTICALS LTD.Inventors: Mayank Saxena, Rikin Patel, Piyush Kansagra, Balvir Singh, Ashish Sehgal
-
Patent number: 11826449Abstract: A method for stabilizing retinoic acid precursors and a skin benefit composition with stabilized retinoic acid precursors are described. The composition has a retinoic acid precursor and a resorcinol to impede oxidation of the precursor in situ in the composition.Type: GrantFiled: April 5, 2022Date of Patent: November 28, 2023Assignee: Conopco, Inc.Inventors: Anjing Lou, Teanoosh Moaddel, Anil Babubhai Patel
-
Patent number: 11801219Abstract: A pouch product comprising a sealable pouch material comprising i) 0 to 10 wt % Cannabis, ii) 0 to 10 wt % nicotine, whereby nicotine is present in the form of iia) tobacco or iib) as nicotine pure and as nicotine salicylic acid salt at a ratio of pure to salt of 0.20-1:1, and up to of one or more 100 wt % of iii) a sweetener, iv) a pH regulator, and v) essential oil as taste agent. The filling material further comprises vi) up to 76 wt % of a filler consisting of vi-1) 42 to 60 wt % microcrystalline cellulose and vi-2) 11 to 22 wt % potato fibers, at a ratio of 2.0-5:1, and vii) 0.1 to 5 wt % of xanthan gum as a wetting agent, whereby the ratio between microcrystalline cellulose, potato fibers and xanthan gum is 1.0-5:1:0.001-0.4.Type: GrantFiled: September 21, 2020Date of Patent: October 31, 2023Inventor: Evaggelos Schjölin
-
Patent number: 11793735Abstract: An aluminum-free antiperspirant/deodorant composition is disclosed. The antiperspirant/deodorant may include an oil-in-water emulsion base and an antiperspirant active dispersed in the oil-in-water emulsion base. The antiperspirant active may be primarily a zinc-based antiperspirant active and the oil-in-water emulsion base may include an emulsifier comprising a mixture of steareth-2 and steareth-20; a plant-based oil, a polyol, and water.Type: GrantFiled: December 8, 2017Date of Patent: October 24, 2023Assignee: Colgate-Palmolive CompanyInventors: Peter Hilliard, Jr., Sharon Kennedy, Cristina Bielli, Richard Adams
-
Patent number: 11766452Abstract: An improved aqueous teat dip comprising iodine and chlorhexidine in an aqueous solution.Type: GrantFiled: December 10, 2020Date of Patent: September 26, 2023Assignee: Webco Chemical CorporationInventor: Michael J. Loosemore
-
Patent number: 11752106Abstract: The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.Type: GrantFiled: September 15, 2021Date of Patent: September 12, 2023Assignee: Vertex Pharmaceuticals IncorporatedInventors: Eleni Dokou, Shahla Jamzad, John P. Caesar, Jr., Majed Fawaz, Laura Das, Chong-Hui Gu, Patricia Nell Hurter, Meghna Jai Israni, Meghan M. Johnston, Dragutin Knezic, Andrew G. Kuzmission, HongRen Wang
-
Patent number: 11738041Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.Type: GrantFiled: April 19, 2022Date of Patent: August 29, 2023Assignee: RENOSIS, INC.Inventors: Gerrit Klaerner, Eric F. Connor, Randi K. Gbur, Matthew J. Kade, Paul H. Kierstead, Jerry M. Buysse, Michael J. Cope, Kalpesh N. Biyani, Son H. Nguyen, Scott M. Tabakman
-
Patent number: 11730852Abstract: Disclosed herein are embodiments of a wound care material with a material which is a composite of a matrix component comprising a flexible hydrophilic polymer foam or fiber matrix comprising two matrix faces providing a release face and a reverse face or two release faces, and therebetween a structural matrix framework defining a network of cells having a cell network surface and therein a network of pores or cell openings, and a powder charge component comprising antimicrobial additive or wound care additive, wherein said powder charge is comprised at one said release face or both said faces and/or within said cell network.Type: GrantFiled: July 12, 2018Date of Patent: August 22, 2023Assignee: Smith & Nephew PLCInventors: Amy Brewster, Robert Crump, Helene Anne Lecomte, David Stephenson, Matthew Wray
-
Patent number: 11701362Abstract: Provided are formulations and dosage forms of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide, alternatively named (1s,4s)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)amino)-8-((2,4,6-trichlorophenyl)amino)-9H-purin-9-yl)-1-methylcyclohexane-1-carboxamide, or a pharmaceutically acceptable salt, tautomer, solvate, hydrate, co-crystal, clathrate, or polymorph thereof.Type: GrantFiled: December 22, 2020Date of Patent: July 18, 2023Assignee: Celgene CorporationInventors: Scott Bone, Tracy Lee Gaebele, Yu Pu, Lianfeng Huang
-
Patent number: 11690886Abstract: The present invention relates to the combination of a retinoid and an extract of Silybum marianum (L.) Gaertn., the dermatological and dermocosmetic compositions containing such a combination, as well as their uses as a medicinal product, in particular in the treatment of acne, seborrhea, seborrhoeic dermatitis and/or rosacea.Type: GrantFiled: December 20, 2018Date of Patent: July 4, 2023Assignee: PIERRE FABRE DERMO-COSMETIQUEInventors: Jean-Hilaire Saurat, Olivier Sorg
-
Patent number: 11660313Abstract: Disclosed herein are compositions that can form a covering, layer, film, device, and/or prosthetic skin that can be comfortably worn to provide skin barrier function, skin hydration and therapeutic and aesthetic benefits. The present invention provides novel compositions that have low tackiness and form quickly, resulting in a wearable, comfortable (maintains temperature and humidity), breathable, thin, optically invisible, cosmetically elegant, flexible, stretchable, elastic and body-movement conforming, yet long-lasting covering, layer, film, device, and/or prosthetic skin on the skin or any other body surface. The present invention provides novel compositions that can form a covering, layer, film, device, and/or prosthetic skin that works for extended periods in excess of about 24 hours, while retaining function during and after exercising, showering and swimming (in sea-water, fresh water and chlorinated water), steam room (heat at high humidity), and sauna (heat at low humidity).Type: GrantFiled: December 31, 2020Date of Patent: May 30, 2023Assignee: Shiseido Company, LimitedInventors: Ariya Akthakul, Nithin Ramadurai, Amir Nashat, Daniela Beccati, Melaney Bouthillette
-
Patent number: 11590075Abstract: The present disclosure relates to methods and products for reducing adhesions. In certain embodiments, the present disclosure provides a method of reducing adhesions in a subject, the method comprising exposing a region in the subject susceptible to formation of an adhesion to an agent having iron chelation and/or antioxidant activity, thereby reducing adhesions in the subject.Type: GrantFiled: February 27, 2018Date of Patent: February 28, 2023Assignee: The University of AdelaideInventors: Sarah Vreugde, Peter John Wormald